AllPennyStocks.com SLS, IBRX Stocks In Focus: Analyst Says Moderna-Merck Cancer Vaccine Success ‘Bodes Well’ For Oncology
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

SLS, IBRX Stocks In Focus: Analyst Says Moderna-Merck Cancer Vaccine Success ‘Bodes Well’ For Oncology

Moderna soared 177% Wednesday, while Merck gained 13% and the rally spread to BioNTech, Arcturus, Tempus AI and Novavax.

Other Penny Stock Movers

A $1 Billion Crypto Deal Sends This Microcap Surging
Chilean Gold Developer Gains 15% on Final Permit Clearance
Chile Copper Explorer Gains 19% on 795m Porphyry Hit
Most Popular
{{ index + 1 }}


Back to Top